Vinyas Innovative Technologies Ltd Q3 FY26 Earnings Analysis

- Vinyas Innovative Technologies expects a sustained growth rate of 30%-35% year-on-year over the next 3-4 years, considered a conservative estimate. - H1 FY '26 revenue grew by 43%, exceeding guidance but the company maintains 30%-35% as the target growth range. - Order book visibility stands at Rs. 1,062 crores with a mix of short and long-term orders largely from defense and aerospace, supporting multi-year growth. - The company aims to increase capacity utilization from 35%-40% currently to 50%-60% by end FY 2026 and 70%-75% by end FY 2027. - Planned capacity expansion (CAPEX) is expected to double production capacity and come online by April 2027, enabling higher revenue capability (~Rs. 1,100-1,200 crores at current capacity). - Growth driven primarily by defense, aerospace (70%-75% revenue share), industrial electronics, and expanding medical devices verticals.

- Vinyas anticipates sustaining a 30%-35% year-on-year revenue growth over the next 3-4 years. - EBITDA margins expected to remain between 9%-11% currently, with an internal target to improve by approximately 3 basis points over 4 years. - Growth in EBITDA margins is linked to improving program mix, focusing on higher gross margin and system integration projects. - Profit after tax showed a 33% increase in H1 FY '26; continued operational strength is expected. - Order book of Rs. 1,062 crores offers multi-year revenue visibility, supporting consistent earnings growth. - Expansion and capacity additions aim to double revenue capacity by April 2027, fueling future earnings. - The company is diversifying into commercial aerospace and medical devices, broadening revenue streams and profitability prospects.

- Current CAPEX includes Rs. 30 crores earmarked from a recent Rs. 150 crore capital raise. - The CAPEX focuses primarily on the electronic manufacturing segment, specifically: - Adding SMT (Surface Mount Technology) lines to increase PCB assembly capacity. - Investing in testing and quality inspection equipment. - The current capacity expansion is expected to be operational by April 2027, approximately 18 months from now. - This expansion aims to double existing capacity, enabling revenue potential of Rs. 1,100-1,200 crores. - Working capital from the capital raise will support growth and administrative expenses. - The company plans to continue infrastructure enhancements to support a 30-35% annual growth over the next 3-4 years. - Capacity approval timelines are significant, hence investment and preparation have commenced early.

- The company completed a capital raise of Rs. 150.04 crores recently, with Rs. 61 crores received in September 2025. - This capital raise is being used for working capital, capacity expansion, and some administrative expenses. - For the next 3 years, the current working capital and funds raised are expected to be sufficient for growth. - Future evaluation of working capital needs and fundraising will depend on program approvals and order pipeline. - No specific mention of planned new fundraising through debt or equity beyond the current capital raise as of now. - The company is monitoring requirements and will adjust funding plans as necessary based on business growth and program needs.

- Current order book stands at approximately Rs. 1,062 crores. - Orders to be executed over the next 18-24 months. - Order pipeline driven by: - Existing defense business - System integration business - Vertical expansion - Technology transfers expected in short and medium term - Major portion of pipeline is the PCBA (Printed Circuit Board Assembly) business. - System integration segment expected to grow significantly over next 3-4 years. - Internal target is to maintain an order book sufficient to cover 24 months of requirements aligned with revenue growth. - The order book includes a mix of short-term and long-term orders, with defense and aerospace forming the large share. - Working on multiple defense programs with some being sole vendor, providing good visibility for the next 5 years.